James Nisco joined Caladrius Biosciences in 2012. As Vice President of Finance & Treasury, he is responsible for SEC reporting, financial reporting and accounting, treasury operations and financial planning and analysis. Mr. Nisco currently oversees all finance activities for the Company while Caladrius conducts its search for a new chief financial officer.
With over 25 years of experience in corporate finance, James has held various senior finance positions prior to Caladrius at OSI Pharmaceuticals, Inc., (acquired by Astellas) and Ciba Corporation (acquired by The BASF Group). James began his career at Ciba-Geigy (now Novartis Pharmaceuticals).
Mr. Nisco holds an MBA in Financial Management from Pace University and a Bachelor of Science in Business Economics from the State University of New York, College at Oneonta.